Rank in Pharmaceuticals: 3
(Previous rank: 2)
Overall score: 6.72
Why it's admiredJ&J has been in better health. The company maintains an impressive portfolio of products and brands that millions of people around the world rely on for their everyday skin care, baby care and first aid, but it had a rough year.
After more than half a dozen recalls of nonprescription drugs, including Tylenol, Benadryl and Motrin, CEO William C. Weldon apologized to lawmakers at a Congressional hearing in September. Its DePuy Orthopaedics unit also recalled two hip implant systems in August.
Yet J&J maintained its position as a multibillion-dollar pharmaceutical company.
In a recent earnings report, Weldon said: "Although 2010 was a challenging year, the business continued to deliver earnings growth, while investing in the future and emerging a stronger organization." --T.M.
Should Johnson & Johnson be admired, or what?
Johnson & Johnson stats